HIMS & HERS HEALTH INC (HIMS) Stock News
NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock
HIMS Latest News and Analysis
Hims & Hers Health: A Stock to Trade or Own?
HIMS achieved remarkable growth in 2024 but now faces challenges in 2025, raising the question of whether it suits traders better than long-term investors.
Why the high growth investor may take a look at NYSE:HIMS.
Unlocking the high Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS).
Noteworthy Friday Option Activity: UNH, HIMS, IGT
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today
Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
Here are three low-priced stocks you can buy today that are positioned in sector that make them solid choices to double in 2025
Is Hims & Hers Stock in Trouble?
Evaluating NYSE:HIMS for Growth Investment Opportunities.
Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?
Noteworthy Wednesday Option Activity: SNPS, FTAI, HIMS
IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List
Compounders now have until late March to wind down their operations, depending on their licensing.
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
4 Stocks That Crushed Analyst Estimates by More Than Double
Hims & Hers, Alcoa, Vicor, and Stride crushed earnings with massive EPS beats. See what’s driving their growth and future potential.
Amazon’s Healthcare Gamble: A New Era of Medical Disruption
Amazon's strategic healthcare expansion leverages technology and logistics for a potentially transformative impact on patient care and market dynamics.